Genome-wide association studies (GWAS) provide a powerful means of identifying genetic variants that play a role in common diseases. Such studies present important ethical challenges. An increasing number of GWAS is taking place in lower income countries and there is a pressing need to identify the particular ethical challenges arising in such contexts. In this paper, we draw upon the experiences of the MalariaGEN Consortium to identify specific ethical issues raised by such research in Africa, Asia and Oceania.

Original publication

DOI

10.1186/1472-6939-12-5

Type

Journal article

Journal

BMC medical ethics

Publication Date

01/2011

Volume

12

Pages

5 - 5